RENIN INHIBITORS

Morpholine dopamine agonists

Piperidine and morpholine renin inhibitors

Renin Inhibitors

Cationic Lipids and Uses Thereof

Ligands for monoamine receptors and transporters, and methods of use thereof

CYCLOPENTADIENYL, INDENYL OR FLUORENYL SUBSTITUTED PHOSPHINE COMPOUNDS AND THEIR USE IN CATALYTIC REACTIONS

Diaryl Ureas as CB1 Antagonists

Process for trans-4-amino-1-cyclohexanecarboxylic acid derivatives

Preparation and Use of Aryl Alkyl Acid Derivatives for the Treatment of Obesity

AMIDE RESORCINOL COMPOUNDS

N-(2-amino-phenyl)-amide derivatives

Diaminopropanol renin inhibitors

Compounds I

MORPHOLIN-ACETAMIDE DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY DISEASES

Intermediate compound for synthesizing pharmaceutical agent and production method thereof

Process for the preparation of delmopinol and derivatives thereof

SYNTHESIS OF 3-[4-(1,1-DIMETHYL-PROPYL)-PHENYL]-2-METHYL-PROPIONALDEHYDE AND cis-4--2,6-DIMETHYL-MORPHOLINE (AMOROLFINE)

N-Benzyl-Morpholine Derivatives as Modulators of the Chemokine Receptor

4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases

Heterocyclic compounds as ccr2b antagonists

Compounds, their preparation and use

METHODS OF USING AS ANALGESICS 1-BENZYL-1-HYDROXY-2,3-DIAMINO-PROPYL AMINES, 3-BENZYL-3-HYDROXY-2-AMINO-PROPIONIC ACID AMIDES AND RELATED COMPOUNDS

Substituted phenylamino-benzene derivatives useful for treating hyper-proliferative disorders and diseases associated with mitogen extracellular kinase activity

Biaromatic compounds which activate PPARγ type receptors and cosmetic/pharmaceutical compositions comprised thereof

Substituted bicyclic derivatives and use thereof

Process for trans-4-amino-1-cyclohexanecarboxylic acid derivatives

3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immuno stimulant activity

Process for the preparation of 2-(4-hydroxy-3-morfolynil)-2-cyclohexenone

Substituted aryl acylthioureas and related compounds; inhibitors of viral replication

Processes For Preparing Bicyclic Oxazine Carboxaldehyde and Beta-Lactamase Inhibitors

Therapeutic Compounds

3-heteroaryl-3-hydroxy-2-amino-propyl amines and related compounds having analgesic and/or immuno stimlant activity

ARYLTHIOACETAMIDE CARBOXYLATE DERIVATIVES AS FKBP INHIBITORS FOR THE TREATMENT OF NEUROLOGICAL DISEASES

Bis-cationic compounds and use thereof

Substituted morpholinyl compounds

Heterocyclic analgesic compounds and methods of use thereof

Aquaporin modulators and methods of using them for the treatment of edema and fluid imbalance

Tetra-cyclic carboline derivatives useful in the inhibition of angiogenesis

Novel Compounds

Hydrofluoroether compounds and processes for their preparation and use

Hemiasterlin Derivatives and Uses Thereof

Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them

MATRIX METALLOPROTEASE INHIBITORS

Process for trans-4-amino-1-cyclohexanecarboxilic acid derivatives

Morpholine compound

3-(2-acylamino-1-hydroxyethyl)-morpholine derivatives and their use as bace inhibitors

Viral polymerase inhibitors

Therapeutic piperazines

Compounds which modulate the CB2 receptor

Preparation of 2-(2-arylmorpholin-2-yl) ethanol derivatives and intermediates

Xanthones, thioxanthones and acridinones as DNA-PK inhibitors

Compounds for the treatment of inflammatory disorders and microbial diseases

Compounds and methods for inhibiting the interaction of BCL proteins with binding partners

Certain chemical entities, compositions, and methods

Sulfonyloxy derivatives

Morpholine derivatives as norepinephrine reuptake inhibitors

Apoptosis promoters

Cyclopropyl amines as modulators of the histamine Hreceptor

Morpholine derivatives as norepinephrine reuptake inhibitors

Apoptosis promoters

Pharmaceutical salts of reboxetine

Derivatives of hydroxamic acid as metalloproteinase inhibitors

1,2-di(cyclic) substituted benzene compounds

Morpholine dopamine agonists

Structural carotenoid analogs for the inhibition and amelioration of disease

Isophthalates as beta-secretase inhibitors

Phenyl and pyridyl LTA4H modulators

Process for producing enantiopure β-amino acid derivatives, and enantiopure β-amino acid derivatives

Morpholine derivatives as 5HT2C receptor agonists for the treatment of obesity

Cell adhesion inhibitors

Substituted aniline derivatives

Hemiasterlin derivatives and uses thereof

Preparation of 2-(2-arylmorpholin-2-yl) ethanol derivatives and intermediates

Arylsulfonamide derivatives

Cyclic hydroxylamine as psychoactive compounds

Mitotic kinesin inhibitors

Benzenesulphonate salt of a morpholine urea derivative for use as a CCR-3 antagonist in the treatment of inflammatory conditions

Morpholin-acetamide derivatives for the treatment of inflammatory diseases

Aryl-substituted heterocyclic enaminones

Hydroxamic acids useful in the treatment of hyper-proliferative disorders

N-benzyl-3-phenyl-3-heterocyclyl-propionamide compounds as tachykinin and/or serotonin reuptake inhibitors

N-2s-4-3,4-difluorobenzyl morpholin-2yl methyl -2-(3-methylsulphonyl amino!phenyl acetamide as ccr3 antagonist for the treatment of inflammatory conditions

Benzyl morpholine derivatives

Substituted N-arylsulfonylheterocyclic amines as gamma-secretase inhibitors

2-(phenoxymethyl)-and 2-(phenylthiomethyl)-morpholine derivatives for use as selective norepinephrine reuptake inhibitors

Substituted aryl acylthioureas and related compounds; inhibitors of viral replication

Aryl and heteroaryl morpholine derivatives

Hydroxamic acid derivative and MMP inhibitor containing the same as active ingredient

Novel compounds of proline and morpholine derivatives

Biaromatic compounds which activate PPARγ type receptors and cosmetic/pharmaceutical compositions comprised thereof

Novel compounds

Substituted morpholine compounds for the treatment of central nervous system disorders

Diphenyl cyclopentyl amides as cannabinoid-1 receptor inverse agonists

Process for producing trans-4-amino-1-cyclohexanecarboxilic acid derivative

Process for the preparation of morpholine derivatives and intermediates therefore

TACE inhibitors

Metal chelate containing compositions for use in chemiluminescent assays

Method for the preparation of aryl ethers

Carboxylic acid amides

Aryl aniline derivatives as βadrenergic receptor agonists

Heterocyclic ketone and thioester compounds and uses

Carotenoid ether analogs or derivatives for controlling connexin 43 expression

Carotenoid analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury

Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor

Carotenoid analogs or derivatives for the inhibition and amelioration of disease

Pleuromutilin derivatives

Supported group 8-10 transition metal olefin polymerization catalysts

Carotenoid ester analogs or derivatives for the inhibition and amelioration of liver disease

Catalysts containing per-ortho aryl substituted aryl or heteroaryl substituted nitrogen donors

Method of treating addiction or dependence using a ligand for a monamine receptor or transporter

Pharmaceutical compositions including carotenoid analogs or derivatives for the inhabition and amelioration of disease

Pharmaceutical compositions including carotenoid ester analogs or derivatives for the inhibition and amelioration of disease

Carotenoid ether analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury

Pharmaceutical compositions including carotenoid ether analogs or derivatives for the inhibition and amelioration of disease

Carotenoid analogs or derivatives for controlling C-reactive protein levels

Carotenoid ester analogs or derivatives for controlling C-reactive protein levels

Carotenoid ether analogs or derivatives for controlling C-reactive protein levels

Carotenoid ester analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury

Carotenoid ether analogs or derivatives for the inhibition and amelioration of liver disease

Process for the preparation of 2-or-9-oxa-3, 7-diazabicyclo (3.3.1) nonanes from 2-aminomethyl-2, 3-dihydrooxazines intermediates therefore, and processes for preparing such intermediates

Carotenoid analogs or derivatives for controlling expression

Carotenoid ester analogs or derivatives for controlling connexin 43 expression

Carotenoid ether analogs or derivatives for the inhibition and amelioration of disease

Carotenoid analogs or derivatives for the inhibition and amelioration of liver disease

(S)-2-((S)-(2-ethoxyphenoxy)(phenyl)methyl)-4-nitrosomorpholine

Crystalline chloro-n-(4-(morpholinomethyl)phenyl)benzamide and crystalline hydrochloride salt

Chemosensitization of resistant by synthetically related compounds

Chemosensitization of resistant by synthetically related compounds

Oleanolic acid methyl ester derivatives